MYCN and neuroblastoma: Currently, NB diagnosis relies on a combination approaches of laboratory tests, radiographic imaging, and pathological examination, considering clinical risk factors such as tumor spread, age at diagnosis, and molecular risk factors including MYCN oncogene amplification, diploid DNA contents, and specific segmental chromosomal aberrations, such as 11q deletion, 1p deletion and 17q gain [3,10].